In the 4T1.2 triple-negative breast cancer (TNBC) mouse model, ILC3s are recruited to the primary tumors by CCL21 and stimulate tumor stromal cells to release CXCL13, leading to enhanced tumor cell motility, lymphangiogenesis, and lymph node invasion by tumor cells (74). This evidence concerns the gene CXCL13 and neoplasm.